CHOLESTEROL DRUG COMPANIES UNDER THE GUN AS PATENTS EXPIRE

A shakeup is swirling through the cholesterol market, one of the most profitable for the drug industry in recent years, as two mainstays have been hit by generic competition this year and giant Pfizer Inc. is rushing to protect its Lipitor franchise.

Globe and Mail (http://www.theglobeandmail.com/servlet/story/LAC.20061010.RCHOLESTEROL10/TPStory/Business)